Proteomic analysis of balding and non-balding mesenchyme-derived dermal papilla cells from androgenetic alopecia patients using on-line two-dimensional reversed phase-reversed phase LC-MS/MS

Journal of Proteomics

Volumn 85, Issue , 2013, Pages 174-191

  Moon, Pyong Gon ^a   Kwack, Mi Hee ^a   Lee, Jeong Eun ^a   Cho, Young Eun ^a   Park, Ji Hwan ^b   Hwang, Daehee ^b   Kim, Moon Kyu ^a   Kim, Jung Chul ^a   Sung, Young Kwan ^a   Baek, Moon Chang ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Androgenetic alopecia; Baldness; Label free protein quantitation; Mesenchyme derived dermal papilla cells; Two dimensional reversed phase reversed phase

Indexed keywords

ARGININOSUCCINATE SYNTHASE; ARGININOSUCCINATE SYNTHASE 1; CARBOXYLASE; CYTOSKELETON ASSOCIATED PROTEIN 4; CYTOSKELETON PROTEIN; FODRIN; GELSOLIN; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; PHOSPHORIBOSYL AMINOIMIDAZOLE CARBOXYLASE; PLECTIN; PLECTIN 1; S PHASE KINASE ASSOCIATED PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 1; SPTAN1 PROTEIN; UNCLASSIFIED DRUG;

ALOPECIA; ARTICLE; AUTOMATION; BIOINFORMATICS; CASE REPORT; CELL ADHESION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIGESTION; GEL; HAIR FOLLICLE; HAIR TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MALE; MALE TYPE ALOPECIA; MASS SPECTROMETER; MESENCHYME CELL; MESENCHYME DERIVED DERMAL PAPILLA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEOMICS; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVERSED PHASE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; SCALP; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SKIN CELL; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

ADULT; ALOPECIA; DERMIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION; HUMANS; MALE; MASS SPECTROMETRY; PROTEOME; PROTEOMICS;

EID: 84878553867     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.04.004     Document Type: Article

References (65)

1. Hardy M.H. The secret life of the hair follicle. Trends Genet 1992, 8:55-61.
2. Botchkarev V.A., Kishimoto J. Molecular control of epithelial-mesenchymal interactions during hair follicle cycling. J Investig Dermatol Symp Proc 2003, 8:46-55.
3. Millar S.E. Molecular mechanisms regulating hair follicle development. J Invest Dermatol 2002, 118:216-225.
4. Stenn K.S., Paus R. Controls of hair follicle cycling. Physiol Rev 2001, 81:449-494.
5. Rushan X., Fei H., Zhirong M., Yu-Zhang W. Identification of proteins involved in aggregation of human dermal papilla cells by proteomics. J Dermatol Sci 2007, 48:189-197.
6. Price V.H., Menefee E., Sanchez M., Ruane P., Kaufman K.D. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1mg, daily. J Am Acad Dermatol 2002, 46:517-523.
7. Rushton D.H., Ramsay I.D., Norris M.J., Gilkes J.J. Natural progression of male pattern baldness in young men. Clin Exp Dermatol 1991, 16:188-192.
8. Jahoda C.A. Cellular and developmental aspects of androgenetic alopecia. Exp Dermatol 1998, 7:235-248.
9. Hamada K., Randall V.A. Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a key to male pattern baldness. Br J Dermatol 2006, 154:609-618.
10. Midorikawa T., Chikazawa T., Yoshino T., Takada K., Arase S. Different gene expression profile observed in dermal papilla cells related to androgenic alopecia by DNA macroarray analysis. J Dermatol Sci 2004, 36:25-32.
11. Bahta A.W., Farjo N., Farjo B., Philpott M.P. Premature senescence of balding dermal papilla cells in vitro is associated with p16(INK4a) expression. J Invest Dermatol 2008, 128:1088-1094.
12. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001, 19:242-247.
13. Gilar M., Olivova P., Chakraborty A.B., Jaworski A., Geromanos S.J., Gebler J.C. Comparison of 1-D and 2-D LC MS/MS methods for proteomic analysis of human serum. Electrophoresis 2009, 30:1157-1167.
14. Gilar M., Olivova P., Daly A.E., Gebler J.C. Orthogonality of separation in two-dimensional liquid chromatography. Anal Chem 2005, 77:6426-6434.
15. Liu Y., Xu Q., Xue X., Zhang F., Liang X. Two-dimensional LC-MS analysis of components in Swertia franchetiana Smith. J Sep Sci 2008, 31:935-944.
16. Marchetti N., Fairchild J.N., Guiochon G. Comprehensive off-line, two-dimensional liquid chromatography. Application to the separation of peptide digests. Anal Chem. 2008, 80:2756-2767.
17. Motoyama A., Venable J.D., Ruse C.I., Yates J.R. Automated ultra-high-pressure multidimensional protein identification technology (UHP-MudPIT) for improved peptide identification of proteomic samples. Anal Chem 2006, 78:5109-5118.
18. Murphy R.E., Schure M.R., Foley J.P. Effect of sampling rate on resolution in comprehensive two-dimensional liquid chromatography. Anal Chem 1998, 70:1585-1594.
19. Donato P., Cacciola F., Sommella E., Fanali C., Dugo L., Dacha M., et al. Online comprehensive RPLC×RPLC with mass spectrometry detection for the analysis of proteome samples. Anal Chem 2011, 83:2485-2491.
20. Han C.L., Chien C.W., Chen W.C., Chen Y.R., Wu C.P., Li H., et al. A multiplexed quantitative strategy for membrane proteomics: opportunities for mining therapeutic targets for autosomal dominant polycystic kidney disease. Mol Cell Proteomics 2008, 7:1983-1997.
21. Tsou C.C., Tsai C.F., Tsui Y.H., Sudhir P.R., Wang Y.T., Chen Y.J., et al. IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation. Mol Cell Proteomics 2010, 9:131-144.
22. Miranda B.H., Tobin D.J., Sharpe D.T., Randall V.A. Intermediate hair follicles: a new more clinically relevant model for hair growth investigations. Br J Dermatol 2010, 163:287-295.
23. Moon P.G., Lee J.E., You S., Kim T.K., Cho J.H., Kim I.S., et al. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. Proteomics 2011, 11:2459-2475.
24. Cho Y.E., Singh T.S., Lee H.C., Moon P.G., Lee J.E., Lee M.H., et al. In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach. Mol Cell Proteomics 2012, 11. [M111 010884].
25. Silva J.C., Denny R., Dorschel C.A., Gorenstein M., Kass I.J., Li G.Z., et al. Quantitative proteomic analysis by accurate mass retention time pairs. Anal Chem 2005, 77:2187-2200.
26. Vissers J.P., Pons S., Hulin A., Tissier R., Berdeaux A., Connolly J.B., et al. The use of proteome similarity for the qualitative and quantitative profiling of reperfused myocardium. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:1317-1326.
27. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
28. Silva J.C., Gorenstein M.V., Li G.Z., Vissers J.P., Geromanos S.J. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics 2006, 5:144-156.
29. Vissers J.P., Langridge J.I., Aerts J.M. Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease. Mol Cell Proteomics 2007, 6:755-766.
30. Bostanci N., Heywood W., Mills K., Parkar M., Nibali L., Donos N. Application of label-free absolute quantitative proteomics in human gingival crevicular fluid by LC/MS E (gingival exudatome). J Proteome Res 2010, 9:2191-2199.
31. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3.
32. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13:2498-2504.
33. Klipper-Aurbach Y., Wasserman M., Braunspiegel-Weintrob N., Borstein D., Peleg S., Assa S., et al. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 1995, 45:486-490.
34. Rorabacher D.B. Statistical treatment for rejection of deviant values: critical values of Dixon's "Q" parameter and related subrange ratios at the 95% confidence level. Anal Chem 1991, 63:139-146.
35. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-14868.
36. Geromanos S.J., Vissers J.P., Silva J.C., Dorschel C.A., Li G.Z., Gorenstein M.V., et al. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS. Proteomics 2009, 9:1683-1695.
37. Hibberts N.A., Howell A.E., Randall V.A. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 1998, 156:59-65.
38. Itami S., Inui S. Role of androgen in mesenchymal epithelial interactions in human hair follicle. J Investig Dermatol Symp Proc 2005, 10:209-211.
39. Nakanishi S., Itami S., Adachi K., Takayasu S. Expression of androgen receptor, type I and type II 5α-reductase in human dermal papilla cells. Hair Research for the Next Millennium 1996, Elsevier, Amsterdam. D. Neste, V.A. Randall (Eds.).
40. Asada Y., Sonoda T., Ojiro M., Kurata S., Sato T., Ezaki T., et al. 5 Alpha-reductase type 2 is constitutively expressed in the dermal papilla and connective tissue sheath of the hair follicle in vivo but not during culture in vitro. J Clin Endocrinol Metab 2001, 86:2875-2880.
41. Soni V.K. Androgenic alopecia: a counterproductive outcome of the anabolic effect of androgens. Med Hypotheses 2009, 73:420-426.
42. Ellis J.A., Scurrah K.J., Cobb J.E., Zaloumis S.G., Duncan A.E., Harrap S.B. Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. Hum Genet 2007, 121:451-457.
43. Zhuo F.L., Xu W., Wang L., Wu Y., Xu Z.L., Zhao J.Y. Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis. Clin Exp Dermatol. 2011, 37:104-111.
44. Rathnayake D., Sinclair R. Male androgenetic alopecia. Expert Opin Pharmacother 2010, 11:1295-1304.
45. Olsen E.A. Efficacy of finasteride 1mg in the treatment of androgenetic alopecia in men. Exp Dermatol 1999, 8:302-303.
46. Olsen E.A., Weiner M.S. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment. J Am Acad Dermatol 1987, 17:97-101.
47. Lee Y.J., Rice R.H., Lee Y.M. Proteome analysis of human hair shaft: from protein identification to posttranslational modification. Mol Cell Proteomics 2006, 5:789-800.
48. Li G.Z., Vissers J.P., Silva J.C., Golick D., Gorenstein M.V., Geromanos S.J. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics 2009, 9:1696-1719.
49. Bondarenko P.V., Chelius D., Shaler T.A. Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal Chem 2002, 74:4741-4749.
50. Chelius D., Bondarenko P.V. Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J Proteome Res 2002, 1:317-323.
51. Wang W., Zhou H., Lin H., Roy S., Shaler T.A., Hill L.R., et al. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal Chem 2003, 75:4818-4826.
52. Jaffe J.D., Mani D.R., Leptos K.C., Church G.M., Gillette M.A., Carr S.A. PEPPeR, a platform for experimental proteomic pattern recognition. Mol Cell Proteomics 2006, 5:1927-1941.
53. Han C.L., Chen J.S., Chan E.C., Wu C.P., Yu K.H., Chen K.T., et al. An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer. Mol Cell Proteomics 2011, 10. [M110 003087].
54. Johnson M., Sharma M., Henderson B.R. IQGAP1 regulation and roles in cancer. Cell Signal 2009, 21:1471-1478.
55. Kwiatkowski D.J. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol 1999, 11:103-108.
56. Sun H.Q., Yamamoto M., Mejillano M., Yin H.L. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem 1999, 274:33179-33182.
57. Fujita H., Allen P.G., Janmey P.A., Azuma T., Kwiatkowski D.J., Stossel T.P., et al. Induction of apoptosis by gelsolin truncates. Ann N Y Acad Sci 1999, 886:217-220.
58. Koya R.C., Fujita H., Shimizu S., Ohtsu M., Takimoto M., Tsujimoto Y., et al. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J Biol Chem 2000, 275:15343-15349.
59. El-Domyati M., Attia S., Saleh F., Bassyouni M.I., El-Fakahany H., Abdel-Wahab H. Proliferation, DNA repair and apoptosis in androgenetic alopecia. J Eur Acad Dermatol Venereol 2009, 23:7-12.
60. Nishimura K., Ting H.J., Harada Y., Tokizane T., Nonomura N., Kang H.Y., et al. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Res 2003, 63:4888-4894.
61. Inui S., Itami S. Androgen receptor transactivity is potentiated by TGF-beta1 through Smad3 but checked by its coactivator Hic-5/ARA55 in balding dermal papilla cells. J Dermatol Sci 2011, 64:149-151.
62. McMahon L.W., Walsh C.E., Lambert M.W. Human alpha spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex. J Biol Chem 1999, 274:32904-32908.
63. Sridharan D., Brown M., Lambert W.C., McMahon L.W., Lambert M.W. Nonerythroid alphaII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links. J Cell Sci 2003, 116:823-835.
64. Hijikata T., Nakamura A., Isokawa K., Imamura M., Yuasa K., Ishikawa R., et al. Plectin 1 links intermediate filaments to costameric sarcolemma through beta-synemin, alpha-dystrobrevin and actin. J Cell Sci 2008, 121:2062-2074.
65. Niwa T., Saito H., Imajoh-ohmi S., Kaminishi M., Seto Y., Miki Y., et al. BRCA2 interacts with the cytoskeletal linker protein plectin to form a complex controlling centrosome localization. Cancer Sci 2009, 100:2115-2125.